Projects Supported by BIRAC under Mission COVID Suraksha
S.No.Applicant NameProposal TitleCityState
1 Biological E Limited To develop a safe, immunogenic & stable vaccine for all populations against the novel coronavirus COVID-19 which is affordable and accessible for all countries. HYDERABAD TELANGANA
2 Gennova Biopharmaceuticals Limited Clinical studies of indigenous COVID-19 mRNA vaccine candidate, HGCO19. Pune MAHARASHTRA
3 Inst Life Sci, BBSR Establishment of a platform for experimental animal models to carryout preclinical evaluation of candidate antivirals and vaccines against SARS-CoV2 Bhubaneswar ORISSA
4 Interactive Research School for Health Affairs, Pune Capacity enhancement of National Immunogenicity and Biologics Evaluation Center for assessing the immunogenicity of SARS-CoV-2 vaccines Pune MAHARASHTRA
5 Indian Institute of Science Bangalore Augmentation of Viral BSL3 facility and development of Cell Culture and Animal Models for for evaluation of COVID-19 vaccine candidates Bangalore KARNATAKA
6 Syngene International Limited Upgradation/strengthening of facilities for conduct of immunoassays specifically available for COVID-19 vaccine developers to help accelerate development of COVID-19 vaccines in the pipeline. The laboratory aims to transfer/develop and validate assays to support immunogenicity assessment for clinical trial testing of COVID-19 vaccine candidates. Bangalore KARNATAKA
7 National Centre for Biological Sciences, Bangalore Enabling preclinical studies for Covid-19 research, diagnostics and drug development Bangalore KARNATAKA
8 THSTI NCR BIOTECH SCIENCE CLUSTER Cellular assay platform for determining the immunogenicity of vaccine candidates. FARIDABAD HARYANA
9 Medanta Institute of Education and Research To establish a GCP compliant hospital based Clinical research site for conduct of Human clinical trials for COVID-19 Vaccine candidates. New Delhi DELHI
10 Gokulaeducationfoundation Enhancing capacity for conduct of Human clinical trials for COVID-19 vaccine candidates at Ramaiah Medical College and Hospitals Bengaluru KARNATAKA
11 ICMR - National Institute of Epidemiology Enhancing the capacity of Model Rural Health Research Unit, Tirunelveli to conduct human clinical trials for COVID 19 vaccine candidates Chennai TAMIL NADU
12 MALABAR CANCER CENTRE Enhancing capacity for conduct of Human clinical trials for COVID-19 Vaccine candidates THALASSERY KERALA
13 BAPS PRAMUKH SWAMI HOSPITAL Proposal for Grant to Enhance the Clinical Research Department capacity to conduct Covid-19 Vaccine candidate human clinical trials on a large scale. SURAT GUJARAT
14 Amrita Institute of Medical Sciences and Research Centre To establish and enhance capacity for conduct of Human Clinical Trials for COVID-19 vaccine candidates. Kochi KERALA
15 Bharat Biotech International Limited Development of a Single Dose Intranasal SARS-CoV-2 vaccine HYDERABAD TELANGANA
16 JSS Academy of Higher Education and Research Capacity building of Infrastructure and human resource for conducting COVID Vaccine clinical trials and immunogenicity studies as per GCP guidelines. Mysore KARNATAKA
17 Christian Medical College Vellore Association To set-up a Clinical Trial Unit CTU capable of testing COVID-19 vaccine candidates in CMC Vellore Vellore TAMIL NADU
18 JIPMER COVID-VaTSU: Establishing a COVID Vaccine Trials Support Unit at JIPMER, Puducherry Puducherry PONDICHERRY
19 Tata Memorial Centre Strengthening of clinical trial unit for conduct of COVID-19 Vaccine trials among cancer patients and healthy volunteers Parel, Mumbai-400012 MAHARASHTRA
20 Society for Applied Studies Strengthening of a GCP compliant field site in an urban community in Delhi to accelerate Phase 2/3 COVID-19 vaccine trials in India Kolkata WEST BENGAL
21 ANDHRA MEDICAL COLLEGE Strengthening the capacity for conduct of Human clinical trials for COVID-19 Vaccine at Andhra Medical College, VIsakhapatnam. Visakhapatnam ANDHRA PRADESH
22 KEM Hospital Research Centre, Pune Enhancing capacity of KEM Hospital Research Centre, Pune for conduction of community-based human clinical trials on vaccines for COVID-19 Pune MAHARASHTRA
23 Kasturba Health Society Strengthening organizational capacity for community based clinical trials on Covid-19 and other priority public health issues Wardha MAHARASHTRA
24 KEM Hospital Research Centre, Pune Enhancing capacity of KEM Hospital Research Centre Pune for conduct of hospital-based human clinical trials of vaccines for COVID-19 Pune MAHARASHTRA
25 The INCLEN Trust International Enhancing capacity for conduct of community based clinical trials for vaccine candidates at a newly established Demographic Development and Environmental Surveillance Site in East Khasi Hills District, Meghalaya New Delhi DELHI
26 Zydus Lifesciences Limited Phase-3 Clinical Trial of Novel Corona Virus-2019-nCov vaccine ZyCoV-D candidate developed by M/s Cadila Healthcare Limited. Ahmedabad GUJARAT
27 Symbiosis International University Building a trial administration team to support all activities required for effective implementation and management of the trial Training on GCP and GPP for research team of Investigators/Co-investigators, physician, coordinators, nurses, lab technicians, and field workers relevant to conducting vaccine trials Conducting clinical trials for vaccine companies developing COVID-19 vaccine, with the help of well experienced research staff. Pune MAHARASHTRA
28 Genique Lifesciences Private Limited A Phase 1/2/3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of Virus-Like Particle-based, PRAK-03202, Vaccine Candidates Against COVID-19 Gurgaon HARYANA
29 SRM Institute of Science and Technology (SRM MEDICAL COLLEGE HOSPITAL AND RESEARCH CENTRE) Establishment of Clinical Trial Unit for evaluation of COVID vaccines CHENGALPET TAMIL NADU
30 Christian Medical College Ludhiana Establishment of Hub and Spoke model for conducting COVID Vaccine Trials on Human participants in Ludhiana HELICAL Ludhiana PUNJAB
31 Indian Immunologicals Limited PROPOSAL FOR FACILITY AUGMENTATION TO SUPPORT COVID VACCINE MANUFACTURING UNDER MISSION COVID SURAKSHA Hyderabad TELANGANA
32 Bharat Biotech International Limited Proposal for facility augmentation to support COVID vaccine manufacturing HYDERABAD TELANGANA
33 Inst Life Sci, BBSR Establish state of the art clinical-immunogenicity assay platform to facilitate COVID-19 vaccine development Bhubaneswar ORISSA
34 THSTI NCR BIOTECH SCIENCE CLUSTER SARS-CoV-2 animal challenge model for pre-clinical and translational research FARIDABAD HARYANA
35 Ins for stem cell biology andregenerative medicine Enabling COVID-19 vaccine and therapeutics development using animal models Bangalore KARNATAKA
36 Mazumdar Shaw Medical Foundation Establishment of a NABL Accredited Laboratory for Performing Clinical Immunogenicity Testing Bangalore KARNATAKA
37 Jawaharlal Nehru Centre for Advanced Scientific Research Engineering conditionally replication-competent SARS-CoV-2 viral molecular clones and evaluation of cross-variant neutralization Bangalore KARNATAKA
38 Gujarat Biotechnology Research Centre Proposal for Facility Augmentation for to support Covid Vaccine Manufacturing under Mission Covid Suraksha Gandhinagar GUJARAT
39 Inst Life Sci, BBSR Identification and validation of potential drug candidates against COVID-19-associated lung fibrosis using clinically relevant in vitro and in vivo models Bhubaneswar ORISSA
40 Jawaharlal Nehru Centre for Advanced Scientific Research Antibiotic-adjuvant therapy to target bacterial pulmonary infections and associated infection Bangalore KARNATAKA
41 Indian Institute of Science Bangalore Development of Auranofin in Combination with Direct Acting Antivirals as Therapy against COVID-19 Bangalore KARNATAKA
42 Ahammune Biosciences Private Limited Identification of new therapeutic interventions that focus on pulmonary fibrosis and associated inflammation Pune MAHARASHTRA
43 Central Drug Research Institute Lucknow (CDRI) Therapeutic Targeting of Neutrophil Extracellular Traps NETs in Pulmonary Fibrosis Lucknow UTTAR PRADESH
44 Foundation for Neglected Disease Research Development of in vitro and in vivo models for vaccine and post COVID-19 induced pulmonary fibrosis Bengaluru KARNATAKA
45 Pandorum Technologies Private Limited Development and Validation of human airway organoid models for modeling post COVID19 associated ARDS, COPD and Fibrosis related pathologies and drug discovery. Bengaluru KARNATAKA
46 INSTITUTE OF CHEMICAL TECHNOLOGY, Mumbai Development and validation of in-vitro assays for evaluation of drugs for COVID associated health complications. Mumbai MAHARASHTRA
47 Regional Center for Biotechnology Dietary alpha-ketoglutarate as a potential therapeutic against acute respiratory distress syndrome ARDS and pulmonary fibrosis in COVID-19 infection Faridabad HARYANA
48 THSTI NCR BIOTECH SCIENCE CLUSTER Pre-clinical animal model platform to study disease severity and post COVID-19 sequelae. FARIDABAD HARYANA
49 International Center of Genetic Engineering and Biotechnology ICGEB Preclinical development of broadly neutralizing SARS-CoV-2 specific human monoclonal antibodies New Delhi DELHI
50 Institute for Stem Cell Science and Regenerative Medicine Insights into the pathogenesis and long-term effects of SARS-Cov-2 variants from structural and immunological perspectives enabling the development of new antiviral modalities Bangalore KARNATAKA
51 Mazumdar Shaw Medical Foundation Repurposing of ANTI-LCN2 MAB as anti-fibrotic drug Bangalore KARNATAKA
52 Eyestem Research Private Limited To investigate the anti-fibrotic potential of iPSC-derived lung cells against COVID-19 induced pulmonary fibrosis Ahmedabad GUJARAT
Report Generated through BIRAC 3i